Professional Documents
Culture Documents
The Pathophysiology of Labyrinthitis: Clinical
The Pathophysiology of Labyrinthitis: Clinical
The pathophysiology
of labyrinthitis
Joanne Mildenhall is a Paramedic, Newbury Ambulance Station, South Central Ambulance Service NHS Trust.
Email for correspondance: jo.mildenhall@scas.nhs.uk
Table 1. Plasma derived mediations of (Gopen et al, 2006; Keithley et al, 2008), and
has the ability to cause morphological alteration
inflammation and dysfunction of sensory cells, resulting in an
Kinins e.g. bradykinin Causes increased capillary permeability and pain irreversible hearing loss (Hughes and Pensak,
2008).
Complement Causes vasodilation and increased vascular Labyrinthitis may also occur following the
permeability, promotes leukocyte activation, spread of pneumococcai associated with bacterial
adhesion and chemotaxis, and activates meningitis from the brain into the labyrinth via the
phagocytosis. internal auditory canal, cochlear aqueduct (which
contains a small amount of dura-mater, creating a
direct link between the perilymphatic space and
the subarachnoid space) or from destruction of the
blood-labyrinthine barrier (similar to the blood-brain
barrier) (Tarlow, 1998; Lee, 2002). Subsequently,
passage of endotoxins and chemical mediators
(Klein et al, 2008) into this delicate area obliterates
cochlea hair cells (stereocilia) within the Organ of
Corti, which are involved in the transmission of
sound vibrations to the vestibulocochlear nerve
(Allen, 2006). In conjunction with spiral ganglion
neuronal cell death situated just prior to the start of
the cochlea nerve, irreversible hearing loss occurs
(Son et al, 2008).
Viral infection
Viral insult, on the other hand, is the most common
pathogenic factor of human labyrinthitis (Swartz
and Longwell, 2005). It is frequently associated as a
complication of influenza, colds, upper respiratory
tract infections or viral otitis media (Vergisen, 2008).
Replication of viruses (protein-coated nucleic
acids) occurs by the hijacking of host cells and
stimulating ribosomal protein synthesis (Marieb,
Figure 1. The labyrinth (or inner ear) houses the delicate 1998; Underwood, 2004; Mattson-Porth, 2007).
membranous structures necessary for hearing and balance. Pathogenically, it is still not known exactly how
the causal relationship between the virus and
humans and animals have identified bacterial otitis labyrinthitis occurs, however, there is evidence
media (middle ear infection/ inflammation) as a to support congenital transmission in utero
significantly influential factor in the development of from rubella and cytomegalovirus (Katano et
labyrinthitis pathophysiology (Goebel, 2008). al, 2007; Cheeran et al, 2009) or transmission as
Primarily, a build-up of infective discharge a characteristic of systemic viral illness such as
reaches a small chamber that is in direct contact influenza, human immunodeficiency virus (Teggi et
with the round window (Cureoglu et al, 2005). al, 2008) or mumps, for example.
This precipitate consists of toxins (Yukiko, 2005), In the case of mumps, histopathological
enzymes and inflammatory chemicals that form research (Katsuhiko et al, 1988; Guyot, 1999) has
exudate/pus, and will eventually leave the ear as identified haematogenical spread in the form of
suppurative otorrhoea. Within this small chamber a viraemia, producing an infection of the stria
is a potential space: the perilymphatic space, vascularis (external wall of the cochlea duct which
containing the fluid perilymph. Proliferation of the is highly vascularised and secretes endolymph).
discharge subsequently extends to the potassium This alters the chemical composition and volume
rich endolymph within the membranous labyrinth. of endolymph, causing irritation as in serous
The interference of the homeostatic environment labyrinthitis. Subsequently, a mild to moderate
of the perilymphatic and endolymphatic fluids unilateral or bilateral hearing loss is experienced
within the labyrinth by bacterial toxins and (Merchant et al, 2008). Sudden vertigo also prevails
inflammatory mediators causes irritation, and also and is often incapacitating.
triggers an inflammatory response. This produces
an inflammatory response within the cochlea Immune/inflammatory response
Arachidonic acid Arachidonic acid is a fatty acid which causes synthesis of prostaglandins via the cyclo-oxygenase pathway, and synthesis of
leukotrienes via the lipoxygenase pathway
Platelet activating Cause platelet aggregation and primes and enhances the functions of neutrophils and factors monocytes, and is a potent
eosinophil attractor. Is also a potent vasodilator of the capillaries at the site of the inflammation
Cytokines Proteins (such as interferon) which cause a variety of effects including activation of T, B and proteins
natural killer cells. Induces fever and stimulates neutrophil production. Induces the inflammatory response
Interleukin 2 A cytokine derived from white blood cells (leukocytes)
Nitrous oxide A messenger molecule that relaxes smooth muscles, reduces platelet aggregation and adhesion, kills microbes via
phagocytic cells
Prostaglandin A fatty acid made in the body that has several functions including causing inflammation in areas of damaged tissue.
Mattson-Porth (2007) and Marieb (1998)
The release of exudate increases the 2), to travel from the endolymphatic sac to
inflammatory response and initiates the migration physiologically alter the endothelial cells of the
of immune system cells into the area. The spiral modiolar vein of the inner ear (Berrocal and
continued activation of cytokines stimulates Ramirez-Camacho, 2002), allowing more immune
a different type of cytokine, interleukin-2 (IL- system cells to diffuse from the circulation into the
affected area. It also acts chemotactically to draw that a small rise in temperature enhances immune
these cells into the perilymph. Interestingly, studies function, as there is a positive correlation in white
have recently identified that IL-2 is only detected blood cell activity, T cell activation and interferon
in perilymph if stimulating pathogenic conditions production (Kluger, 1986). Subsequently, the
are present (Hughes and Pensak, 2008; Luxon et al, immune system cells remove the invading particles
2003). Therefore, this seems to be a physiological from the body.
indicator of the presence of labyrinth infection. In conjunction with a mild fever being
However, realistically, this information appears established in labyrinthitis, the immune and
to be of no clinical benefit at the current time, as inflammatory response continues to be active. The
perilymph is not a fluid which is accessible for cellular response is incredibly complex and is not
laboratory testing due to its anatomical location, yet fully understood in terms of any aetiology, let
deep within the temporal bones of the head. alone in the detailed physiology of the inner ear.
Temperature Immunoglobulins
Pyrogenic (heat/fever producing) cytokines such Also activated by the proliferation of cytokines is
as interleukin-1 (IL-1) and tumour necrosing an adaptive humoral immune antigen–antibody
factor alpha (TNF α) are distributed within the response. Composite protein parts of the invading
systemic circulation and act directly upon the microorganism are triggers for such an immune
thermoregulatory centre in the hypothalamus. This response in which antibodies are produced in
acts upon arachidonic acid, and converts it into the body by activated B cells as a defence. These
prostaglandin (PG) E2 via the cyclo-oxygenase defenders are also referred to as immunoglobulins
pathway (Underwood, 2004; Guyton and Hall, and are resident within the blood as the gamma-
2006). This chemical not only induces inflammation globulin protein portion (Mattson-Porth, 2007).
and exacerbates the effects of histamine and other In terms of inner ear defence, once an invading
inflammatory mediators, but also displaces the pathogen has been established by primary
body’s thermostat to a higher temperature; having mechanisms, immunoglobulins are stimulated
the systemic effect of initiating heat producing to cross the blood—labyrinthine barrier (similar
physiological mechanisms such as mild tachycardia to the blood—brain barrier) into the inner ear.
and tachypnoea, and activation of hepatic processes Similarly, immunoglobulin’s are thought to enter the
(Marieb, 1998). perilymph and endolymph via the perilymphatic
Similarly, heat conserving behaviours such as blood vessels (Luxon et al, 2003). However, many
shivering and vasoconstriction are also experienced, researchers believe that certain immunoglobulin’s
giving rise to the feeling of being hot yet cold. reside permanently within the inner ear fluids in a
Confirmation of a recorded temperature above 38˚C concentrated form, as in cerebrospinal fluid (Hughes
in association with these symptoms is characteristic and Pensak, 2008).
of a fever (NHS Direct, 2010). Fever is indicative to Fundamentally, it is known that immunoglobulin’s
the clinician that an infection is present. Once the IgA, IgG, and IgM play a key role in the humoral
pathogen has been removed, and cytokine expression immune response to inner ear infection. IgG, for
subsides to normal, then the fever will resolve and example, is a widely available antibody within the
the hypothalamus will reset to the normal parameters plasma, and is the main fighter in this immune
of body temperature (35.5–37.5˚C) (Sund-Lavander, response. Certainly, IgG2 has been shown to be
Forsberg and Wahren, 2002). particularly effective against bacteria such as
A thorough systematic history-taking will usually S. pneumoniae and H. influenzae—both of which
determine the nature and location of the infection. are capable of causing otitis media, which can lead
Although in some cases, investigations such as to labyrinthitis. IgA, on the other hand, is limited
urine analysis or CRP (C-Reactive Protein) blood within the plasma but is abundant within other
testing, as part of a full blood count, may be body fluids. It is thought to be in significant volume
necessary. This however, should not normally be in labyrinthine fluids and plays a role in preventing
required in the case of a labyrinthine infection. microorganisms in attaching to epithelium.
A rise in body temperature was often thought IgM is an important antibody because it activates
of as a physiological method of ‘cooking’ the and works collaboratively with the complement
pathogen to destroy it, but what has been system. It does this by binding to the infected cell,
known for some time is that microbes optimally which expresses viral proteins on its membranous
proliferate and grow when internal conditions surface (Rhoades and Pflanzer, 2002). This
are approximately 36.2˚C. At significantly higher binding of antibodies to the surface antigen
temperatures, the pathogen is simply unable to morphologically alters its structure, enabling
grow (Mains et al, 2008). It has been established chemo-attraction of the primary component of
the complement cascade to the base of the ‘Y’ ‘uncoating’ occurs whereby degradation of the
shaped antibody in a region known as the fragment protein coat by enzymes results in the release of
crystallisable region. the viral genomic nucleic acid (ribonucleic acid
Activation of the classical complement system (RNA) or deoxyribonucleic acid (DNA)). Synthesis
(C3b pathway) stimulates cell lysis via phagocytic of viral proteins and the genome are required for
opsonization of the microbe (Marieb, 1998; Ravetch replication. Transcription from viral messenger
and Bolland, 2001). RNA occurs within the host cell cytoplasm, giving
an expression of genes required to reproduce the
Viral management virus. This is translated into a protein ‘list’ upon
Essentially, antibodies also provide an immune which replication occurs via ribosomal protein
response to free viruses by binding to them, synthesis.
effaciously prohibiting their adherence to, and It is at this transcription and translation stage that
invasion of a host cell. Critically, viruses such small protein cytokines, interferons, are activated
as rhinoviruses, influenza and adenoviruses are by the host immune system to interfere with viral
pathogens that can initiate labyrinthitis. In order replication (Marieb, 1998; Mattson-Porth, 2007).
for these acellular organisms to replicate, they Interferon alpha (IFN α) and interferon beta
must assemble within a host cell. This replicative (IFN β) are produced by a variety of cells, and
process primarily occurs with ‘attachment’ diffuse to nearby uninfected cells binding with
whereby the proteinous, viral-encoded genome receptors on its cell membrane. Here, they stimulate
coat of the virus specifically binds to receptors synthesis of an enzyme; protein kinase R (PKR),
on the membranous surface of the host cell. This which is significant in the inhibition of ribosomal
specificity determines which host cells the virus protein synthesis, thereby interfering with viral
will favour, they will only ‘choose’ cells in which replication (Sherwood, 2005).
they are capable of replicating. Interferon gamma (IFN γ) provides the initial
Attachment to the host membrane receptor adaptive immune by activating the localization of
results in a pathophysiological alteration of normal macrophages and natural killer cells.
cell function by inducing the construction of a Interestingly, the pharmacological intra-nasal
‘lipoprotein envelope’ to provide the virus with use of interferons for viral upper respiratory
morphological distinction from other pathogens, tract infections is currently being used in Eastern
and which allows for the fusion of viral and cellular Europe and Russia (Kreider et al, 1998; Ison et
membranes (Mattson-Porth, 2007: 31). al, 2004). While many researchers are sceptical
Antibodies, however, provide an acute humoral of their use (as the exact actions of interferon
neutralization response to prevent the virus from upon otorhinolaryngological structures are not yet
attaching to the host cell. This requires a highly understood), a contemporary study being jointly
specific interaction (induced fit) between the undertaken in the UK and USA is examining
antigen and antibody. Antibody recognition of pharmaceutical interferon use for otitis illnesses
specific antigenic epitopes (small, unique chemical (Garrett-Nichols et al, 2008). It must be noted
units within the virus) allows complementary that a pharmaceutical company is supporting this
convergence at the fragment antigen-binding site of work and therefore this may be influential in any
the antibody; which are situated at the tips of its ‘Y’ outcomes.
shaped structure (Mattson-Porth, 2007). However, studies now identify that some viruses
Finally, immunoglobulin’s also contribute to viral have evolved to inhibit interferon production and
defence by stimulating a cell-mediated response. function (Katze et al, 2002), with implications for
Primarily, this is by infiltration of macrophages successful immuno-ability to combat previously short-
to the infected area, but also involves specialized lived infections. While further scientific exploration of
cells such as natural killer, cytotoxic CD8+ T, these pathogens and counteractive pharmaceuticals
CD4+ T cells and interferon. Natural killer cells, is required, perhaps the focus should widen to
for example, provide a rapid non-specific cellular take account of the influential holistic factors in the
immune response prior to the activation of proliferation and transference of pathogens; namely
cytotoxic CD8+ T cells. They adhere to the infected the environmental and social determinants of health
cell membrane upon primary exposure, and cause (Vergison, 2008) which have so recently been
apoptosis cell death by cytotoxic lysis of the fundamental in the spread of viral influenza A (Swine
membrane (Sherwood, 2005). Flu) (World Health Organisation, 2009). Additionally,
If the virus is able to overcome this initial assault personal factors that impinge on the effectiveness
by the host immune system, it enters the host cell of the immune system and inflammatory response,
following membrane fusion or through receptor such as dietary factors and levels of stress, require
mediated endocytosis. Subsequently, a period of consideration to promote health.
Conclusion
As it remains, the current UK best practice in Key points
treating labyrinthitis pharmacologically is by over- llLabyrinthitis is an inflammation of the inner ear in
the-counter medications such as paracetamol for response to infection. This illness has the potential to
fever and pain management, and allowing the cause temporary or permanent hearing loss, with other
body to undertake its natural course in managing symptoms including earache and fever.
the illness (NHS Choices, 2010). However, if
symptoms are severe, vestibular suppressants llAetiology of labyrinthitis are attributable to bacterial,
may be prescribed for dizziness; antiemetics viral and fungal insult. However, fungal infections are
given for nausea/ sickness; steroids for reducing less common than the other two.
inflammation, and if the cause is thought to be
bacterial, antibiotics may be required. llRegardless of cause, the complex inflammatory and
To conclude, labyrinthitis is generally a short- immune response is activated to locally defend the
lived minor illness that has the potential to cause inner ear structures, and systemically defend the body
temporary or permanent disablement in terms of against infection.
hearing loss. Understanding the pathophysiological
development and the inflammatory and immune llTreatments include over-the-counter medications such
response to such an illness enables the clinician as paracetemol for fever and pain management, and
to comprehend the underlying processes of the allowing the body to take its natural course in managing
presenting signs and symptoms, and to treat the illness. However, if symptoms are severe, anti-emetics
accordingly. may be prescribed for nausea; steroids for reducing
inflammation; vestibular suppressants for dizziness; and
Allen S (2006) Inner ear disorders and hearing. The
Pharmaceutical Journal 276, 143–46
antibiotics if the cause is suspected to be bacterial.
Berrocal JRG, Ramirez-Camacho R (2002) Immune response and
immunopathology of the inner ear: an update. J Laryngol Otol
114(2): 101–7
Boston ME, Strasnick B, Steinberg AR (2008) Inner ear, Otology and Neurotology 29(6): 854–59
labyrinthitis. http://tinyurl.com/36uof68 (accessed 6 July Klein M, Koedel U, Kastenbauer S et al (2008) Nitrogen and
2010) oxygen molecules in meningitis associated labyrinthitis and
Cheeran MCJ, Lokensgard JR, Scleiss MR (2009) hearing impairment. Infection 36(1): 2–14
Neuropathogenesis of congenital cytomegalovirus infection: Kluger MJ (1986) Is fever beneficial? Yale J Biol Med 59(2): 89–95
disease mechanisms and prospects for intervention. Clin Kreider RB, Fry AC, O’Toole ML (1998) Overtraining in Sport.
Microbiol Rev 22(1): 99–126 Human Kinetics Europe Ltd, Leeds
Cureoglu S, Schachern PA, Rinaldo A et al (2005) Round Kumar P and Clark M (eds) (2005) Clinical Medicine. 6th ed.
window membrane and labyrinthine pathological changes: An Elsevier Saunders, London
Overview. Acta Otolaryngologica 125(9): 15 Lee KJ (2002) Essential Otolaryngology. McGraw Hill, London
Garrett-Nichols W, Peck-Campbell AJP et al (2008) Respiratory Luxon LM, Furman JM, and Martini A (2003) Textbook of
viruses other than influenza virus: impact and therapeutic Audiological Medicine. Taylor and Francis, London
advances. Clin Microbiol Rev 21(2): 274–90 Mains JA, Coxall K, Lloyd H (2008) Measuring Temperature.
Goebal JA (2008) Practical Management of the Dizzy Patient. Nursing Standard 22(39): 44–7
Wolters Kluwer Health, London Marieb EN (1998) Human Anatomy and Physiology, 4th ed
Gopen Q, Keithley EM, and Harris JP (2006) Mechanisms Benjamin Cummings, Harlow
underlying auto-immune inner ear disease, drug discovery
Mattson-Porth C (2007) Essentials of Pathophysiology. 2nd ed.
today. Disease Mechanisms 3(1): 137–42
Lippincott, Williams and Wilkins, London
Guyot JP (1999) Sudden deafness and viral infections. Oto-
Merchant SN, Durand ML, and Adams JC (2008) Sudden
Rhino-Laryngologica 9(5): 190–97
deafness: is it viral? Journal of Otolaryngology 70(1): 52–62
Guyton AC and Hall JE (2006) Textbook of Medical Physiology.
NHS Direct (2010) Fever in adults. http://tinyurl.com/35bqoup
11th ed. Elsevier Saunders, Philadelphia
(accessed 6 July 2010)
Hughes GB, Pensak HL (2007) Clinical Otology. 3rd ed. Thieme
National Health Service Choices (2010) Labyrinthitis.
Publishing Group, London
http://tinyurl.com/26o2oke (accessed 7 July 2010)
Ison MG, Johnston SL, Openshaw P et al (2004) Current research
Ravetch J, Bolland S (2001) IgG Fc Receptors. Annual Review of
on respiratory viral infections: fifth international symposium.
Immunology 19: 275–90
Antiviral Research 62(3): 75–110
Rhoades RA, Pflanzer RG (2002) Human Physiology. 4th ed.
Jayarajan V, Rajenderkumar D (2003) A survey of dizziness
Thompson Learning, London
management in general practice. J Laryngol Otol 117(8): 599–604
Rouke T, Tassone P, Philpott C et al (2009) ENT cases seen at
Katano H, Sato Y, Tsutsui Y et al (2007) Pathogenesis of
a local walk-in centre: A one year review. The Journal of
cytomegalovirus associated labyrinthitis in a guinea pig model.
Larynology and Otology 123: 339–42
Microbes and Infection 9(2): 183–191
Sanders MJ (2001) Mosby’s Paramedic Textbook.2nd ed. Mosby,
Katsuhiko T, Satoshi F, Tohru S et al (1988) Experimental
Missouri
mumps virus induced labyrinthitis: immunohistochemical and
untrastructural studies. Acta Otolaryngol 105 (S456): 98 – 105 Sherwood L (2005) Fundamentals of Physiology. 3rd ed. Brookes
Cole, Kentucky
Katze MG, He Y, Gale M (2002) Viruses and interferon: a fight
for supremacy. Natural Review of Immunology 2:(9) 675–87 Son HY, Shim HS, Ahn SY et al (2008) A case of suppurative
labyrinthitis complicated by otitis media. Korean Journal of
Keithley EM, Wang X, and Barkdull GC (2008) TNF (Alpha)
Otolaryngology 51(11): 1050–3
can induce recruitment of inflammatory cells to the cochlea.